BYDUREON BCise - AstraZeneca US
See full prescribing information for BYDUREON BCISE.<br/> <br/>BYDUREON BCISE<sup>®</sup> (exenatide) extended-release injectable suspension, for subcutaneous …
Bydureon BCise (exenatide) - Uses, Side Effects, and More - WebMD
2024年6月15日 · What is Bydureon BCise used for? Bydureon BCise (exenatide) is commonly used to help lower blood sugar levels in people with type 2 diabetes. Bydureon BCise may also be used for other...
Bydureon: Uses, Dosage & Side Effects - Drugs.com
2023年8月14日 · Bydureon BCise is an extended release injectable diabetes medicine that helps control blood sugar levels. This medication helps your pancreas produce insulin more efficiently. Bydureon BCise is used together with diet and exercise to improve blood sugar control in people with type 2 diabetes mellitus.
Bydureon BCise Patient Tips: 7 things you should know - Drugs.com
Bydureon BCise is a brand (trade) name for a long-acting form of exenatide which may be used to improve blood glucose control in adults and children over the age of 10 with type 2 diabetes. …
BYDUREON BCISE is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and...
BYDUREON BCISE is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and...
DailyMed - BYDUREON BCISE- exenatide injection, suspension, …
2024年11月1日 · BYDUREON BCISE (exenatide) extended-release injectable suspension is a GLP-1 receptor agonist supplied as a sterile suspension of exenatide extended-release microspheres in an oil-based vehicle of ...
儿童2型糖尿病新药！美国FDA批准Bydureon BCise (艾塞那肽缓释 …
2021年7月24日 · Bydureon BCise（艾塞那肽缓释剂）于2017年10月在美国首次获得批准，作为一种每周一次的单剂量自动注射器，适用于除了控制饮食和加强运动之外、服用一种或多种口服药物仍然无法控制血糖水平的T2D成人患者，以改善血糖控制。 在欧盟，Bydureon BCise于2018年8月获得批准。 近40年前，T2D在儿童中被认为是罕见的。 但自20世纪90年代中期以来，由于超重或肥胖儿童的比例上升，T2D在儿童中的全球发病率一直在上升，特别是在美国。 此次儿科批 …
population Clinical Review Mahtab Niyyati Bydureon (EQW): NDA 022200 Supplement 031 Bydureon BCise (EQWS): NDA 209210 Supplement 017 Table 24: Incidence of elevatedliver function tests, controlled ...
AstraZeneca Medications
The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.